Canada Life’s CytomX Therapeutics CTMX Stock Holding History

Canada Life’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58K	Buy	+15,482	New	+$59.1K	﹤0.01%	1737
2021 Q4	–	Sell	-2,623	Closed	-$13K	–	2518
2021 Q3	$13K	Hold	2,623	–	–	﹤0.01%	2486
2021 Q2	$17K	Hold	2,623	–	–	﹤0.01%	2507
2021 Q1	$20K	Hold	2,623	–	–	﹤0.01%	2505
2020 Q4	$17K	Hold	2,623	–	–	﹤0.01%	2560
2020 Q3	$17K	Hold	2,623	–	–	﹤0.01%	2469
2020 Q2	$22K	Hold	2,623	–	–	﹤0.01%	2476
2020 Q1	$20K	Hold	2,623	–	–	﹤0.01%	2371
2019 Q4	$22K	Buy	+2,623	New	+$17.7K	﹤0.01%	2476
2019 Q3	–	Sell	-4,943	Closed	-$55K	–	1393
2019 Q2	$55K	Hold	4,943	–	–	﹤0.01%	2414
2019 Q1	$53K	Hold	4,943	–	–	﹤0.01%	2243
2018 Q4	$72K	Hold	4,943	–	–	﹤0.01%	2251
2018 Q3	$91K	Hold	4,943	–	–	﹤0.01%	2222
2018 Q2	$113K	Buy	4,943 +3,143	+175%	+$80.3K	﹤0.01%	2147
2018 Q1	$51K	Hold	1,800	–	–	﹤0.01%	2362
2017 Q4	$38K	Hold	1,800	–	–	﹤0.01%	2421
2017 Q3	$32K	Hold	1,800	–	–	﹤0.01%	2424
2017 Q2	$28K	Hold	1,800	–	–	﹤0.01%	2450
2017 Q1	$31K	Hold	1,800	–	–	﹤0.01%	2401
2016 Q4	$20K	Hold	1,800	–	–	﹤0.01%	2491
2016 Q3	$28K	Hold	1,800	–	–	﹤0.01%	2435
2016 Q2	$18K	Buy	+1,800	New	+$20.5K	﹤0.01%	2473

Other funds holding CTMX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Canada Life's CTMX Position: Q2 2026 in Review

Canada Life opened a new position in CytomX Therapeutics (CTMX) in Q2 2026: 15,482 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #1737 among its holdings. This is a return to the name: Canada Life previously reported a position in CTMX as recently as Q3 2021.

Canada Life first reported a position in CTMX in Q2 2016 and has held it in 22 quarters since. The position peaked at $113K in Q2 2018. 179 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

Canada Life held 15,482 shares of CytomX Therapeutics worth $58K as of Q2 2026.
CytomX Therapeutics was a new Canada Life position in Q2 2026.
CytomX Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1737 holding.
Canada Life first reported a position in CytomX Therapeutics in Q2 2016 and has held it in 22 quarters since.
Canada Life's CytomX Therapeutics position peaked at $113K in Q2 2018.
179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.